Russia Radiation Oncology Market Size & Outlook, 2020-2028
Russia radiation oncology market, 2017-2028 (US$M)
Related Markets
Russia radiation oncology market highlights
- The Russia radiation oncology market generated a revenue of USD 121.5 million in 2020 and is expected to reach USD 216.1 million by 2028.
- The Russia market is expected to grow at a CAGR of 7.5% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 121.5 million |
| Market revenue in 2028 | USD 216.1 million |
| Growth rate | 7.5% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, Russia accounted for 1.6% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 500.6 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 69.88% in 2020. Horizon Databook has segmented the Russia radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
Rapid technological advancements and increase in the number of strategic initiatives, such as collaborations & distribution agreements, are among factors anticipated to drive the market growth over the forecast period.
For instance, in January 2020, Alpha Tau Medical Ltd. announced positive results of phase-1 clinical trials for the novel radiotherapy technique, Diffusing Alpha-emitters Radiation Therapy (DaRT). Furthermore, in September 2019, Fabrika RTT (R-Pharm Group) and Varian Medical Systems.
Entered into an agreement for the local assembly of Halcyon system. The agreement aims to assemble 200 units of Halcyon system and is an expansion of previous agreement signed in 2017 for the assembly of Varian Cliniac iX and Unique systems for public hospitals in Russia.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Russia radiation oncology market size, by type, 2017-2028 (US$M)
Russia Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
